Literature DB >> 7126867

Aspirin prolongation of the template bleeding time: influence of venostasis and direction of incision.

C H Mielke.   

Abstract

The template bleeding time is a measure of platelet participation in primary hemostasis. Aspirin alters platelet function through interference with prostaglandin biosynthesis. In many individuals, aspirin will consistently prolong the bleeding time. Despite this observation, normal individuals rarely develop a bleeding disorder. This prompted us to investigate the influence of technical variables on the prolongation of the bleeding time by aspirin. Both direction of incision and venostasis influenced the prolongation of the bleeding time by aspirin. A horizontal incision with venostasis produced the most pronounced prolongation, while a vertical incision without venostasis didn't prolong the bleeding time despite the characteristic changes in platelet aggregation and release. These studies suggest that the influence of aspirin on the template bleeding time is dependent on technical variables and is minimal in the normal subject.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7126867

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Riociguat (BAY 63-2521) and aspirin: a randomized, pharmacodynamic, and pharmacokinetic interaction study.

Authors:  Reiner Frey; Michael Reber; Jörn Krätzschmar; Sigrun Unger; Wolfgang Mück; Georg Wensing
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

2.  Platelet function and coagulation in patients with hepatobiliary disorders receiving cefotetan prophylaxis.

Authors:  D R Triger; R G Malia; F E Preston
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

3.  What about the bleeding time?

Authors:  T J Hamblin
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13

4.  Shortened bleeding time in acute myocardial infarction and its relation to platelet mass.

Authors:  P C Milner; J F Martin
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.